TRPM7 (melastatin) was recently considered in the pathoaetiology of ME/CFS as it participates in several Ca2+-dependent processes that are central to NK cell cytotoxicity which may be compromised in ME/CFS. Here, TRPM7 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.